Eli Lilly & Co. Inc.’s stock rose 1.5% early Wednesday, after the company said its Zepbound weight-loss drug was more effective than rival Novo Nordisk’s Wegovy in a head-to-head study. Zepbound ...
The Dow didn’t hold onto its initial gains as market breadth was weak to start December. The blue-chip index was down 200 points, or 0.5%, after opening the day higher. Within the index, 19 of its 30 ...
The S&P 500 is generally considered the best gauge for the overall U.S. stock market due to its scope and diversity. The five largest components in the index by weight are: The S&P 500's value ...
See how we rate investing products to write unbiased product reviews. The U.S. stock market generally closes for major holidays like Memorial Day, Independence Day, and Thanksgiving. But not all ...
Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Such a proposal could greatly expand the use of weight loss drugs in the U.S. That would benefit Novo ...
Amgen (NASDAQ:AMGN) announced Tuesday that its experimental weight loss therapy MariTide ... Cantor Fitzgerald that caused a selloff in its stock early this month. However, Amgen (AMGN) added ...
Prescription weight loss medications, including GLP-1 agonists, orlistat, and Contrave, may be effective for some people. But other lifestyle changes are still necessary for long-term success.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...